MBL77 OPTIONS

Not all individuals with CLL need therapy. Despite all modern improvements, the iwCLL continue to recommends watchful observation for patients with asymptomatic condition.86 This suggestion is predicated on a minimum of two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FC